benefits of using semaglutide GLP-1 Is Semaglutide Right for You?
Description
FIB-4 cut-off of 1.3 may be inappropriate in a primary care referral pathway for patients with NAFLD

Summary Keywords GLP-1, Alzheimers disease, Parkinsons disease, neuroinflammation, amyloid beta, mitochondrial dysfunction, brain glucose hypometabolism, insulin resistance Citation Reich N and Hlscher C (2022) The neuroprotective effects of glucagon-like peptide 1 in Alzheimers and Parkinsons disease: An in-depth review

Semaglutide is a GLP-1 receptor agonist, which is a clinical way of saying it works by mimicking a natural hormone in your body that regulates appetite

Clinical investigations further confirmed that GLP-1RA treatment led to significant improvements in key pulmonary function parameters, including forced expiratory volume in one second (FEV 1 ), forced vital capacity (FVC), and mid-expiratory flow rates (MEF 75 and MEF 50 )

General GLP?1 counselling Eat slowly, stop at first sign of fullness, separate fluids from meals if reflux occurs, prioritise protein to preserve lean mass, maintain resistance exercise, monitor for gallstone symptoms with rapid weight loss, and review interacting medicines (ie, delayed gastric emptying may alter absorption of some oral drugs)

This allows your body to adjust to the medication, significantly reducing the risk of severe nausea
